UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

The potential of broadly neutralizing antibodies for HIV prevention

Journal of the International AIDS Society, 2024-05, Vol.27 (5), p.e26257-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial

PloS one, 2020-05, Vol.15 (5), p.e0233151-e0233151

2020

Link zum Volltext

Verfügbarkeit prüfen

Mass drug administration for trachoma: how long is not long enough?

PLoS neglected tropical diseases, 2015-03, Vol.9 (3), p.e0003610-e0003610

2015

Link zum Volltext

Verfügbarkeit prüfen

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

iScience, 2023-09, Vol.26 (9), p.107595-107595, Article 107595

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site MHgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South Africa

PloS one, 2016, Vol.11 (4), p.e0152184-e0152184

2016

Link zum Volltext

Verfügbarkeit prüfen

Integrating data and resources on neglected tropical diseases for better planning: the NTD mapping tool (NTDmap.org)

PLoS neglected tropical diseases, 2015-02, Vol.9 (2), p.e0003400

2015

Link zum Volltext

Verfügbarkeit prüfen

Cellular Immune Responses during High-Dose Interferon-α Induction Therapy for Hepatitis C Virus Infection

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.819-828

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature medicine, 2021-10, Vol.27 (10), p.1718-1724

2021

Link zum Volltext

Verfügbarkeit prüfen

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

The lancet HIV, 2019-04, Vol.6 (4), p.e230-e239

2019

Link zum Volltext

Verfügbarkeit prüfen

Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C

Hepatology research, 2012-07, Vol.42 (7), p.668-676

2012

Link zum Volltext

Verfügbarkeit prüfen

Is HIV epidemic control by 2030 realistic?

The lancet HIV, 2024-07, Vol.11 (7), p.e489-e494

2024

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine roll-out in South Africa : the added value of wastewater surveillance for SARS-CoV-2

South African medical journal, 2021-06, Vol.111 (6), p.524-525

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya

Open forum infectious diseases, 2017-01, Vol.4 (1), p.ofw253-ofw253

2017

Link zum Volltext

Verfügbarkeit prüfen

Low-level HCV viraemia after initial response during antiviral therapy : transcription-mediated amplification predicts treatment failure

Antiviral therapy, 2007-01, Vol.12 (3), p.423-427

2007

Link zum Volltext

Verfügbarkeit prüfen

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

Liver international, 2008-01, Vol.28 (1), p.39-46

2008

Link zum Volltext

Verfügbarkeit prüfen

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005–2009

Journal of clinical virology, 2010-06, Vol.48 (2), p.150-151

2010

Link zum Volltext

Verfügbarkeit prüfen

University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude survey

Journal of the International AIDS Society, 2012-02, Vol.15 (1), p.9-9

2012

Link zum Volltext

Verfügbarkeit prüfen

Reply from the authors

Hepatology research, 2012-11, Vol.42 (11), p.1154-1155

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical performance of the new roche COBAS® taqMan HCV test and high pure system for extraction, detection and quantitation of HCV RNA in plasma and serum

Antiviral therapy, 2006, Vol.11 (1), p.95-103

2006

Link zum Volltext

Verfügbarkeit prüfen

Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile

Liver international, 2007-09, Vol.27 (7), p.944-953

2007

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS34A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a

Scandinavian journal of gastroenterology, 2008, Vol.43 (9), p.1122-1127

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus RNA quantification by the COBAS® AmpliPrep® /COBAS® TaqMan® System: Averages do not tell the whole story

Journal of clinical virology, 2007-08, Vol.39 (4), p.326-327

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Humans
(19)
Male
(14)
Female
(13)
Infectious Diseases
(12)
Adult
(11)
Middle Aged
(10)
Biological And Medical Sciences
(8)
Hiv
(8)
Human Immunodeficiency Virus
(8)
Medical Sciences
(8)
Hepacivirus - Isolation & Purification
(7)
Immunology
(7)
Rna, Viral - Blood
(7)
Hepacivirus - Genetics
(6)
Virology
(6)
Acquired Immune Deficiency Syndrome
(5)
Adolescent
(5)
Antiviral Agents
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

The potential of broadly neutralizing antibodies for HIV prevention

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial

Mass drug administration for trachoma: how long is not long enough?

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site MHgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South Africa

Integrating data and resources on neglected tropical diseases for better planning: the NTD mapping tool (NTDmap.org)

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Cellular Immune Responses during High-Dose Interferon-α Induction Therapy for Hepatitis C Virus Infection

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C

Is HIV epidemic control by 2030 realistic?

COVID-19 vaccine roll-out in South Africa : the added value of wastewater surveillance for SARS-CoV-2

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya

Low-level HCV viraemia after initial response during antiviral therapy : transcription-mediated amplification predicts treatment failure

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005–2009

University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude survey

Reply from the authors

Clinical performance of the new roche COBAS® taqMan HCV test and high pure system for extraction, detection and quantitation of HCV RNA in plasma and serum

Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile

Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS34A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a

Hepatitis C virus RNA quantification by the COBAS® AmpliPrep® /COBAS® TaqMan® System: Averages do not tell the whole story

Suchergebnisse filtern